4-HO-MET: Difference between revisions

>Agile
m Pharmacology: Added information about SRI properties.
>Agile
m Updated dangerous interactions with possibility of serotonin syndrome from its SRI properties.
Line 199: Line 199:
{{DangerousInteractions/Psychedelics}}
{{DangerousInteractions/Psychedelics}}


===[[Serotonin syndrome]] risk===
Combinations with the following substances can lead to dangerously high [[serotonin]] levels. Serotonin syndrome requires immediate medical attention and can be fatal if left untreated.
*'''[[DangerousInteraction::MAOIs|MAOIs]]''' such as '''[[syrian rue]]''', '''[[banisteriopsis caapi]]''', '''phenelzine''', '''selegiline''', and '''moclobemide'''<ref>Gillman, P. K. (2005). Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. British Journal of Anaesthesia, 95(4), 434-441. https://doi.org/10.1093/bja/aei210</ref> - MAO-B inhibitors can increase the potency and duration of  phenethylamines unpredictably. MAO-A inhibitors with MDMA will lead to hypertensive crises.
*'''[[UnsafeInteraction::Serotonin releasers]]''' such as '''[[MDMA]]''', '''[[4-FA]]''', '''[[methamphetamine]]''', '''[[methylone]]''' and '''[[αMT]]'''
*'''[[UncertainInteraction::ΑMT|AMT]]'''
*'''[[UnsafeInteraction::2C-T-x|2C-T-x]]'''
*'''[[DangerousInteraction::DXM|DXM]]'''
*'''[[UnsafeInteraction::5-HTP|5-HTP]]'''
==Legal status==
==Legal status==